PubMed=4333982; DOI=10.1073/pnas.69.2.383
Miller G., Shope T.C., Lisco H., Stitt D., Lipman M.
Epstein-Barr virus: transformation, cytopathic changes, and viral antigens in squirrel monkey and marmoset leukocytes.
Proc. Natl. Acad. Sci. U.S.A. 69:383-387(1972)

PubMed=4346033; DOI=10.1073/pnas.70.1.190
Miller G., Lipman M.
Release of infectious Epstein-Barr virus by transformed marmoset leukocytes.
Proc. Natl. Acad. Sci. U.S.A. 70:190-194(1973)

PubMed=4357683; DOI=10.1084/jem.138.6.1398
Miller G., Lipman M.
Comparison of the yield of infectious virus from clones of human and simian lymphoblastoid lines transformed by Epstein-Barr virus.
J. Exp. Med. 138:1398-1412(1973)

PubMed=216485
Higgins N.P., Strauss B.S.
Differences in the ability of human lymphoblastoid lines to exclude bromodeoxyuridine and in their sensitivity to methyl methanesulfonate and to incorporated [3H]thymidine.
Cancer Res. 39:312-320(1979)

PubMed=6294325; DOI=10.1128/JVI.44.3.1088-1091.1982
Skare J., Edson C., Farley J., Strominger J.L.
The B95-8 isolate of Epstein-Barr virus arose from an isolate with a standard genome.
J. Virol. 44:1088-1091(1982)